diagnosing & treating ME/CFS in the time of COVID
Many are experiencing long-term symptoms in the wake of COVID-19. While some may be diagnosed with other post-viral diseases and others will recover, a recent study showed that 50% of COVID “long haulers” meet the diagnostic criteria for myalgic encephalomyelitis/ chronic fatigue syndrome (ME/CFS) at six months. What we know about ME/CFS has grown by leaps and bounds since the National Academy of Medicine report and the resulting surge in clinical research, making it the perfect time to refresh your knowledge of this complex chronic disease.
#MEAction and the University of Rochester presented a Grand Rounds on ME/CFS in the wake of COVID-19 in January 2021. The content was recorded from our August 2020 seminar, with our speakers present for panel-style questions from the audience.
* Note that the presentation below represents the entire presentation shown in August 2020. You may see slides here that are not present in the University of Rochester presentation above.